Literature DB >> 9287177

Immune reconstitution in HIV infection.

S Emery1, H C Lane.   

Abstract

Progressive immune deficiency arising during HIV disease reflects the continual degradation and the ultimate deletion of immune specificites defined by the CD4(+) T lymphocyte repertoire. Recent evidence suggests that improvements in the immune function of patients with HIV who receive therapy primarily reflects the expansion of CD4(+) T lymphocyte populations present before therapy commenced. These observations have implications for clinical management, therapeutic strategies, and future research.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9287177     DOI: 10.1016/s0952-7915(97)80112-4

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  7 in total

1.  Effects of therapy with highly active anti-retroviral therapy (HAART) and IL-2 on CD4+ and CD8+ lymphocyte apoptosis in HIV+ patients.

Authors:  L Caggiari; S Zanussi; M T Bortolin; M D'andrea; G Nasti; C Simonelli; U Tirelli; P De Paoli
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

2.  Sarcoid-like lesions associated with the immune restoration inflammatory syndrome in AIDS: absence of polymerase chain reaction detection of Mycobacterium tuberculosis in granulomas isolated by laser capture microdissection.

Authors:  Sandra Lassalle; Eric Selva; Véronique Hofman; Catherine Butori; Nicolas Vénissac; Jérôme Mouroux; Pierre Dellamonica; Paul Hofman
Journal:  Virchows Arch       Date:  2006-10-17       Impact factor: 4.064

3.  Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with highly active anti-retroviral therapy (HAART) or HAART + IL-2.

Authors:  S Zanussi; C Simonelli; M T Bortolin; M D'Andrea; C Crepaldi; E Vaccher; G Nasti; D Politi; L Barzan; U Tirelli; P De Paoli
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

4.  Enhanced expression of CTLA-4 (CD152) on CD4+ T cells in HIV infection.

Authors:  K Steiner; I Waase; T Rau; M Dietrich; B Fleischer; B M Bröker
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

5.  Changes in thymic function in HIV-positive patients treated with highly active antiretroviral therapy and interleukin-2.

Authors:  P De Paoli; M T Bortolin; S Zanussi; A Monzoni; C Pratesi; M Giacca
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

6.  Increased peripheral expansion of naive CD4+ T cells in vivo after IL-2 treatment of patients with HIV infection.

Authors:  Ven Natarajan; Richard A Lempicki; Irini Sereti; Yunden Badralmaa; Joseph W Adelsberger; Julia A Metcalf; Darue A Prieto; Randy Stevens; Michael W Baseler; Joseph A Kovacs; H Clifford Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

Review 7.  Immune reconstitution inflammatory syndrome after initiating highly active antiretroviral therapy in HIV-infected children.

Authors:  Tracy Kilborn; Marco Zampoli
Journal:  Pediatr Radiol       Date:  2009-03-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.